ARYD — ARYA Sciences Acquisition IV Income Statement
0.000.00%
Last trade - 00:00
- $85.39m
- $87.54m
- 28
- 34
- 40
- 26
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | ||||
Total Operating Expenses | 0.014 | 6.61 | 1.01 | 4.75 |
Operating Profit | -0.014 | -6.61 | -1.01 | -4.75 |
Total Net Non Operating Interest Income / Expense | ||||
Net Income Before Taxes | -0.014 | -6.56 | 1.07 | -2.13 |
Net Income After Taxes | -0.014 | -6.56 | 1.07 | -2.13 |
Net Income Before Extraordinary Items | ||||
Net Income | -0.014 | -6.56 | 1.07 | -2.13 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -0.014 | -6.56 | 1.07 | -2.13 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.001 | -0.397 | 0.056 | -0.217 |
Dividends per Share |